Medical Xpress·3 min read·hard
Novel blood-based biomarker enables early lung cancer detection and prognosis prediction
K
Korea University College of Medicine
✦AI Summary
Researchers have identified a blood-based biomarker using GCC2 protein in extracellular vesicles to detect early-stage lung adenocarcinoma. This discovery offers a potential alternative to invasive biopsies for improved prognosis and treatment.
Why it matters
Early detection of lung cancer significantly improves patient survival rates, making this non-invasive diagnostic tool a major medical advancement.
edited by Gaby Clark , reviewed by Andrew Zinin
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article reports on scientific research findings in a factual, objective manner.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in